| Accentcare Hospice Of California Inc 2344 South Second, Suite B, El Centro, CA, 92243 | |
| (760) 675-3030 |
News Archive
Ingen Technologies, Inc., a medical device manufacturer with an emerging new medical product line targeting the $8B respiratory market, announced today that the company's strategic government contract consultant, KGMA Business Solutions, has scheduled two major tradeshows for August and September, 2010.
"Try after try to make vaginal creams that could repel the AIDS virus have failed. Now researchers are testing if a drug used to treat HIV infection finally might give women a tool to prevent it - by infusing the medicine into vaginal gels and contraceptive-style rings," the Associated Press reports in a piece that examines researchers' latest efforts to create effective HIV microbicides, ahead of the biennial International Microbicides Conference next weekend.
Everything old is new again. As open enrollment gets underway for next year's job-based health insurance coverage, some employees are seeing traditional plans offered alongside or instead of the plans with sky-high deductibles that may have been their only choice in the past.
HP and the African social enterprise mPedigree on Monday announced a new service that will enable patients in Ghana and Nigeria to verify the authenticity of their medications, Fast Company reports. "Counterfeit drugs are estimated to be a $75-billion-per-year business, [and are] implicated in the deaths of something like 700,000 people around the world annually," according to the article (Zax, 12/6).
› Verified 3 days ago
| Name | Accentcare Hospice Of California Inc |
|---|---|
| Location | 2344 South Second, Suite B, El Centro, California |
| Hospice ID | 921522 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Corporation |
| Profit Type | FOR PROFIT |
| Accreditation Provider | Community Health Accreditation Partner (CHAP) |
| SSA county code | 120 |
News Archive
Ingen Technologies, Inc., a medical device manufacturer with an emerging new medical product line targeting the $8B respiratory market, announced today that the company's strategic government contract consultant, KGMA Business Solutions, has scheduled two major tradeshows for August and September, 2010.
"Try after try to make vaginal creams that could repel the AIDS virus have failed. Now researchers are testing if a drug used to treat HIV infection finally might give women a tool to prevent it - by infusing the medicine into vaginal gels and contraceptive-style rings," the Associated Press reports in a piece that examines researchers' latest efforts to create effective HIV microbicides, ahead of the biennial International Microbicides Conference next weekend.
Everything old is new again. As open enrollment gets underway for next year's job-based health insurance coverage, some employees are seeing traditional plans offered alongside or instead of the plans with sky-high deductibles that may have been their only choice in the past.
HP and the African social enterprise mPedigree on Monday announced a new service that will enable patients in Ghana and Nigeria to verify the authenticity of their medications, Fast Company reports. "Counterfeit drugs are estimated to be a $75-billion-per-year business, [and are] implicated in the deaths of something like 700,000 people around the world annually," according to the article (Zax, 12/6).
› Verified 3 days ago
| NPI Number | 1386054989 |
| Organization Name | Accentcare Home Health Of California, Inc. |
| Address | 2344 S 2nd St Ste B El Centro, California, 92243 |
| Phone Number | (760)675-3014 |
News Archive
Ingen Technologies, Inc., a medical device manufacturer with an emerging new medical product line targeting the $8B respiratory market, announced today that the company's strategic government contract consultant, KGMA Business Solutions, has scheduled two major tradeshows for August and September, 2010.
"Try after try to make vaginal creams that could repel the AIDS virus have failed. Now researchers are testing if a drug used to treat HIV infection finally might give women a tool to prevent it - by infusing the medicine into vaginal gels and contraceptive-style rings," the Associated Press reports in a piece that examines researchers' latest efforts to create effective HIV microbicides, ahead of the biennial International Microbicides Conference next weekend.
Everything old is new again. As open enrollment gets underway for next year's job-based health insurance coverage, some employees are seeing traditional plans offered alongside or instead of the plans with sky-high deductibles that may have been their only choice in the past.
HP and the African social enterprise mPedigree on Monday announced a new service that will enable patients in Ghana and Nigeria to verify the authenticity of their medications, Fast Company reports. "Counterfeit drugs are estimated to be a $75-billion-per-year business, [and are] implicated in the deaths of something like 700,000 people around the world annually," according to the article (Zax, 12/6).
› Verified 3 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | Not Available | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | Not Available | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | Not Available | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | Not Available | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | Not Available | 97.3 |
| Patients who got timely treatment for shortness of breath | Not Available | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | Not Available | 93.3 |
News Archive
Ingen Technologies, Inc., a medical device manufacturer with an emerging new medical product line targeting the $8B respiratory market, announced today that the company's strategic government contract consultant, KGMA Business Solutions, has scheduled two major tradeshows for August and September, 2010.
"Try after try to make vaginal creams that could repel the AIDS virus have failed. Now researchers are testing if a drug used to treat HIV infection finally might give women a tool to prevent it - by infusing the medicine into vaginal gels and contraceptive-style rings," the Associated Press reports in a piece that examines researchers' latest efforts to create effective HIV microbicides, ahead of the biennial International Microbicides Conference next weekend.
Everything old is new again. As open enrollment gets underway for next year's job-based health insurance coverage, some employees are seeing traditional plans offered alongside or instead of the plans with sky-high deductibles that may have been their only choice in the past.
HP and the African social enterprise mPedigree on Monday announced a new service that will enable patients in Ghana and Nigeria to verify the authenticity of their medications, Fast Company reports. "Counterfeit drugs are estimated to be a $75-billion-per-year business, [and are] implicated in the deaths of something like 700,000 people around the world annually," according to the article (Zax, 12/6).
› Verified 3 days ago
| Home Health Aides | 0.5 |
| Counselors | 0.5 |
| Homemakers | 0.5 |
| Medical Social Workers | 0.5 |
| Physicians | 1 |
| Registered Nurses | 1 |
| Total Employees | 4 |
|---|
News Archive
Ingen Technologies, Inc., a medical device manufacturer with an emerging new medical product line targeting the $8B respiratory market, announced today that the company's strategic government contract consultant, KGMA Business Solutions, has scheduled two major tradeshows for August and September, 2010.
"Try after try to make vaginal creams that could repel the AIDS virus have failed. Now researchers are testing if a drug used to treat HIV infection finally might give women a tool to prevent it - by infusing the medicine into vaginal gels and contraceptive-style rings," the Associated Press reports in a piece that examines researchers' latest efforts to create effective HIV microbicides, ahead of the biennial International Microbicides Conference next weekend.
Everything old is new again. As open enrollment gets underway for next year's job-based health insurance coverage, some employees are seeing traditional plans offered alongside or instead of the plans with sky-high deductibles that may have been their only choice in the past.
HP and the African social enterprise mPedigree on Monday announced a new service that will enable patients in Ghana and Nigeria to verify the authenticity of their medications, Fast Company reports. "Counterfeit drugs are estimated to be a $75-billion-per-year business, [and are] implicated in the deaths of something like 700,000 people around the world annually," according to the article (Zax, 12/6).
› Verified 3 days ago
| Others | 0.5 |
| Total Volunteers | 0.5 |
|---|
News Archive
Ingen Technologies, Inc., a medical device manufacturer with an emerging new medical product line targeting the $8B respiratory market, announced today that the company's strategic government contract consultant, KGMA Business Solutions, has scheduled two major tradeshows for August and September, 2010.
"Try after try to make vaginal creams that could repel the AIDS virus have failed. Now researchers are testing if a drug used to treat HIV infection finally might give women a tool to prevent it - by infusing the medicine into vaginal gels and contraceptive-style rings," the Associated Press reports in a piece that examines researchers' latest efforts to create effective HIV microbicides, ahead of the biennial International Microbicides Conference next weekend.
Everything old is new again. As open enrollment gets underway for next year's job-based health insurance coverage, some employees are seeing traditional plans offered alongside or instead of the plans with sky-high deductibles that may have been their only choice in the past.
HP and the African social enterprise mPedigree on Monday announced a new service that will enable patients in Ghana and Nigeria to verify the authenticity of their medications, Fast Company reports. "Counterfeit drugs are estimated to be a $75-billion-per-year business, [and are] implicated in the deaths of something like 700,000 people around the world annually," according to the article (Zax, 12/6).
› Verified 3 days ago
| Hospice Of Imperial Valley Location: 137 South 8th Street, El Centro, California, 92243 Phone: (760) 675-3030 |
| Aria Hospice Llc Location: 314 N 8th Street, Suite 6, El Centro, California, 92243 Phone: (760) 675-3030 |
| Accentcare Hospice Of California Inc Location: 2344 South Second, Suite B, El Centro, California, 92243 Phone: (760) 675-3030 |